参考文献/References:
[1] Tracy JA,Bartleson JD.Cervical spondylotic myelopathy[J].Neurologist,2010,16(3):176-187.
[2] Klineberg E.Cervical spondylotic myelopathy:a review of the evidence[J].Orthop Clin North Am,2010,41:193-202.
[3] Toledano M,Bartleson JD.Cervical spondylotic myelopathy[J].Neurologic Clinics,2013,31(1):287-305.
[4] 付昌马,陈惠德,汤健,等.脊髓型颈椎病患者颈椎MRI测量指标及血清免疫球蛋白含量与日本骨科协会颈髓功能评分的相关性[J].中国组织工程研究,2005,9(42):72-74.
[5] Wang KY,Idowu O,Thompson CB,et al.Tract-specific diffusion tensor imaging in cervical spondylotic myelopathy before and after decompressive spinal surgery:preliminary results[J].Clinical Neuroradiology,2017,27(1):1-9.
[6] Yalamanchili PK,Vives MJ,Chaudhary SB.Cervical spondylotic myelopathy:factors in choosing the surgical approach[J].Advances in Orthopedics,2012,2012(6):783762.
[7] Kadaňka Z,Bednarík J,Novotny O,et al.Cervical spondylotic myelopathy:conservative versus surgical treatment after 10 years[J].European Spine Journal,2011,20(9):1533-1538.
[8] 李增春,陈德玉,吴德升,等.第三届全国颈椎病专题座谈会纪要[J].中华外科杂志,2008,46(23):1796-1799.
[9] 国家中医药管理局发布中华人民共和国中医药行业标准——《中医病证诊断疗效标准》[J].中医药管理杂志,1994,(6):2.
[10] 平林冽はか.日本整形外科学会颈髓症治疗成绩判定基准[J].日整会志,1994,68:490-503.